BioSpace News Archive

Sight Sciences, Inc. (Nasdaq: SGHT), today announced plans to participate in the upcoming virtual Morgan Stanley Global Healthcare Conference.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced the closing of its previously announced merger with Aerpio Pharmaceuticals, Inc..

Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, announced the successful completion of its business combination with Alpha Healthcare Acquisition Corp., a special purpose acquisition company sponsored by Constellation Alpha Holdings.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today announced a $350,480 investment in Myosana Therapeutics, Inc.

LivaNova PLC today announced Damien McDonald, Chief Executive Officer, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15 at 9:40 a.m. Eastern Time.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today the recruitment of stem cell pioneer and key opinion leader Francisco Silva to the Company’s Scientific Advisory Board.

Aria Pharmaceuticals, a drug discovery and development company focused on bringing first-in-class small molecules to market, today announced that two novel candidates for the potential treatment of idiopathic pulmonary fibrosis (IPF), TXR-1002 and TXR-1007, demonstrated significant efficacy and excellent tolerability in preclinical studies.

Johnson & Johnson (NYSE: JNJ) will participate in the Cantor Virtual Global Healthcare Conference on Tuesday, September 28th.

Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), announced today it had received its latest U.S. Food and Drug Administration (“FDA”) 510(k) clearance for the Company’s Tibial Revision Knee System, and the PS Plus Posterior Stabilized Tibial Insert, the latest additions to the Sterizo™ Total Knee System.

Lyophilization/ freeze-drying is a process of water removal process in order to preserve perishable materials, extend shelf life or make the product more convenient for transport.